In Vitro Diagnostics Market Dominated by Roche Diagnostics, Abbott Laboratories, Danaher Corporation and Thermo Fisher Scientific by 2023
New report on in vitro diagnostics market forecast and analysis to 2023, highlights the company profiles, competitive landscape, emerging trends, overview. In vitro diagnostics market report also focuses on the geographical regions like North America, Europe and APAC as well.
Pune, India – January 30, 2019 /MarketersMedia/ —
The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. The study estimates the in vitro diagnostics market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from supply side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market.
#Download PDF Brochure of In Vitro Diagnostics market report now at
at https://www.reportsnreports.com/contacts/requestsample.aspx?name=266706 .
Major factors driving growth of In Vitro Diagnostics market in North American region include accessibility to advanced technologies, increasing demand for laboratory automation, expansion of molecular diagnostics for genetic disorders and cancer screening, and presence of major leading companies in the US. This report broadly segments the market into product & service, technology, application, end user, and region.
Growth in the in vitro diagnostics market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories.
#Table of Content
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 In Vitro Diagnostics Market, By Product & Service
8 In Vitro Diagnostics Market, By Technology
9 In Vitro Diagnostics Market, By Application
10 In Vitro Diagnostics Market, By End User
11 In Vitro Diagnostics Market, By Region
12 Competitive Landscape
13 Company Profiles
14 Appendix
#More Details at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=266706 .
North America is expected to command the largest share of In Vitro Diagnostics market in 2018 owing to the availability of government funds, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the region. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China.
Target Audience for this Report:
• IVD Product Manufacturers
• Group Purchase Organizations (GPOs)
• OEM Manufacturers
• Pathologists and Pathology Laboratories
• Distributors of IVD Products
• Hospitals and Clinics
• Healthcare Institutions
• Research Institutes
• Market Research and Consulting Firms
• Venture Capitalists and Investors
Prominent players in in vitro diagnostics market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany)
#Direct Purchase “In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) – Forecast to 2023” Report at https://www.reportsnreports.com/purchase.aspx?name=266706 .
The major factors driving the growth of In Vitro Diagnostics market in the North American region include accessibility to advanced technologies, increasing demand for laboratory automation, expansion of molecular diagnostics for genetic disorders and cancer screening, and presence of major leading companies in the US.
Key Benefits of Buying the Report:
• The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall in vitro diagnostics market and its segments.
• This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies.
• The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
North America is expected to command the largest share of the market in 2018 owing to the availability of government funds, growing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the region. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China.
Contact Info:
Name: Sales
Organization: ReportsandReports
Address: Corporate Headquarters Tower B5, office 101, Magarpatta SEZ, Hadapsar, Pune-411013, India
Phone: +1 888 391 5441
Website: https://www.reportsnreports.com/reports/266706-in-vitro-diagnostic-ivd-market-instruments-reagents-data-management-systems-technique-immunoassay-clinical-chemistry-molecular-diagnostics-haematology-applications-diabetes-infectious-diseases-cancer-cardiology-systems-end-users-forecast.html
Source: MarketersMedia
Release ID: 477483
Copyright © 1999-2013 SproutNews.com
